Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Diagnostics Laboratories (Dx)2.48B78.06%
Biopharma Laboratory Services (BLS)710.9M22.38%
Intercompany eliminations and other-14M-0.44%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
U.S.10.18B83.69%
Europe1.09B9.00%
Other486.46M4.00%
North America402.89M3.31%
